Clinical Trials in Portland

Showing 2781-2800 of 8,670 trials

Post-Market Clinical Investigation of the IotaSOFT Insertion System

NCT06664697

The purpose of the proposed study is to evaluate the continued safety of the iotaSOFT Insertion System when used by a surgeon to assist with inserting a CI electrode array in one ear per subject

Hearing Loss, CochlearCochlear ImplantationHearing Loss, Sensorineural

iotaMotion, Inc.50 participantsStarted Oct 2024

Indianapolis, Indiana, United States • Iowa City, Iowa, United States • Portland, Oregon, United States

TERMINATED< 1 mile

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

NCT03894020

An observational study to evaluate the natural progression of dry AMD in genetically defined subjects

Gyroscope Therapeutics Limited83 participantsStarted Jan 2019

Phoenix, Arizona, United States • Tucson, Arizona, United States • Beverly Hills, California, United States +68 more locations

Post-Market Clinical Investigation of the IotaSOFT Insertion System

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Find Trials by Condition in Portland

A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Entyvio (Vedolizumab) Long Term Safety Study

A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling